Effects of oral valganciclovir prophylaxis for cytomegalovirus infection in heart transplant patients

BACKGROUND: Cytomegalovirus (CMV) infection is a serious complication following heart transplantation. This study (June 2003–January 2010) retrospectively assessed the effects of oral valganciclovir prophylaxis in adult heart transplant recipients during the first year after transplantation. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Doesch, Andreas O, Repp, Janika, Hofmann, Nina, Erbel, Christian, Frankenstein, Lutz, Gleissner, Christian A, Schmidt, Constanze, Ruhparwar, Arjang, Zugck, Christian, Schnitzler, Paul, Ehlermann, Philipp, Dengler, Thomas J, Katus, Hugo A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3472651/
https://www.ncbi.nlm.nih.gov/pubmed/23091373
http://dx.doi.org/10.2147/DDDT.S36578

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3472651/
https://www.ncbi.nlm.nih.gov/pubmed/23091373
http://dx.doi.org/10.2147/DDDT.S36578

Ejemplares similares